Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
REPAIR: Anti-cavity Efficacy of Three Dentifrices
NCT06732518Phase 3Completed
- Sponsor
- Colgate-Palmolive
- Start
- Mar 2025
- Primary completion
- Apr 2025
- Modality
- Peptides, Recombinant Proteins and Enzymes, Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, triple-blind trial of sodium monofluorophosphate and arginine in dental caries (3 arms), sponsored by Colgate-Palmolive. Primary endpoint: Change in enamel microhardness at 5 days. Started Mar 2025; status: completed.
02
Drugs
sodium monofluorophosphatearginine
03
Conditions
dental caries
Beyond the preview
Go deeper on NCT06732518.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06732518.